US Stock MarketDetailed Quotes

CLGN Collplant

Watchlist
  • 4.480
  • +0.232+5.45%
Close Nov 29 13:00 ET
  • 4.200
  • -0.280-6.25%
Post 15:18 ET
51.32MMarket Cap-2928P/E (TTM)

About Collplant Company

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

Company Profile

SymbolCLGN
Company NameCollplant
Listing DateJan 31, 2018
Founded2004
CEOMr. Yehiel Tal
MarketNASDAQ
Employees75
Fiscal Year Ends12-31
AddressWeizmann Science Park,4 Oppenheimer Street
CityRehovot
ProvinceTel Aviv
CountryIsrael
Zip Code7670104
Phone972-73-232-5600
Websitehttp://www.collplant.com

Company Executives

  • Name
  • Position
  • Salary
  • Eran Rotem
  • Deputy Chief Executive Officer and Chief Financial Officer
  • 748.00K
  • Yehiel Tal
  • Chief Executive Officer and Director
  • 1.08M
  • Dr. Elana Gazal, PhD
  • Vice President, Research and Development
  • 379.00K
  • Hadas Dreiher Horowitz
  • Vice President, Human Resources
  • --
  • Oren Fahimipoor
  • Vice President, Operations
  • 323.00K
  • Dr. Philippe Bensimon
  • Vice President, Regulatory Affairs and Quality Assurance
  • 362.00K
  • Dr. Roger J. Pomerantz, F.A.C.P.,M.D.
  • Chairman of the Board
  • --
  • Dr. Elan Penn,PhD
  • Independent Director
  • --
  • Hugh Evans
  • Independent Director
  • --
  • Joseph Zarzewsky
  • Independent Director
  • --
  • Dr. Abraham Havron, PhD
  • Independent Director
  • --
  • Alisa Lask
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data